Our Story

 

Blue-Zone’s story begins in Toronto, Canada in the year 1996. The company’s founder, Ms. Dusanka Filipovic, P. Eng., acquired the global commercialization rights for the Deltasorb® Technology and launched Blue-Zone Technologies Ltd., the world’s first cleantech pharma company.

 

Today Blue-Zone is led by Kipton Lade, CEO and guided by a group of accomplished directors.  The Blue-Zone team is passionate about our planet and dedicated to finding solutions to reduce harmful greenhouse gas emissions, and create a sustainable source of branded generic anesthetics.

Our Vision

 

Is to make a significant contribution to the health and well-being of the communities surrounding Blue-Zone Certified Healthcare facilities worldwide, while building a world renowned, clean-tech pharmaceutical business.

Our Mission

 

Is to reduce hospital’s hazardous environmental waste and lower financial costs by applying Blue-Zone’s patented technology. We collect unused anesthetics that would normally be vented into the environment and process the collected material into its pure form providing a sustainable and cost-efficient source of inhalation anesthetic drugs.

Our Core Values

Our Core values define us as an organization. We pride ourselves on manifesting these values with every human interaction.

Respect

Each person’s authentic self is supported, valued and encouraged.

Accountability

Honour commitments to our customers and each other.

Leadership

Blue-Zone leaders trust their team’s ability to solve complex problems without micromanagement.

Teamwork

Leverage our collective wisdom through trust and collaboration

Stewardship

The well-being and dignity of our employees, customers, and community at the core of every decision.

Leadership Team

Kipton Lade

CEO / Director

Kipton Lade has more than 30 years of successful results-oriented experience in a variety of senior management positions including; C-Suite, General Management, National Sales Management, Global Marketing, Strategic Planning, and Product Development. Uniquely qualified to leverage senior-level management skills, people development, brand positioning, technical expertise, entrepreneurial drive, sales, and marketing know-how to create collaborative and broad solutions to complex challenges while producing successful outcomes, and double-digit sales growth. Proven ability to conceive and implement a global strategic vision while being an entrepreneurial, hands-on leader.

Dusanka Filipovic

Founder / Director

Ms. Dusanka Filipovic, P. Eng., is the co-inventor of the Deltasorb® Technology and Vice Chair and President of the company. She subsequently acquired global commercialization rights for the Deltasorb® Technology from Praxair and launched Blue-Zone Technologies Ltd. Prior to that, while at Union Carbide Canada, she directed the overall development of the Delta™ Project. Ms. Filipovic has experience in the start-up and commercialization of technology-based companies, having served as co-founder & Deputy Chair Halozone Technologies Ltd., a publicly traded company, and E.E.R. Canada, an environmental engineering firm which was acquired by General Electric.

Sean Karamchandani

Director

Sean Karamchandan is an accomplished investor and healthcare entrepreneur. As an investor Sean has deep experience working with global leaders in healthcare service, hospital operations, pharmaceuticals, healthcare policy and biotechnology. As an entrepreneur, Sean founded, developed and commercialized a company focused on insulin digital injection delivery systems, which he sold in 2011. Sean earned an AB in Economics from Harvard University and an MBA from Columbia’s Graduate School of Business.

Paul Weber

Director

Paul Weber is an award-winning Life Sciences entrepreneur with more than two decades of industry experience in building world-class start-ups and scale-ups in the medical technology space. He is currently the Founder and Managing Director of OnPoint Ventures which provides strategic advisory services in the Medtech innovation sector.

David Bacon

Director

David Bacon joined Halocarbon Products Corp. as CEO in 2015. David was the first Halocarbon CEO to be hired from outside the company. His vision is to build the New Halocarbon and position it as the strategic growth partner for innovation in fluorochemistry. David has over 15 years of experience leading businesses in General Manager roles where he consistently improved operations and profitability. Prior to Halocarbon, he served as President of the LSP Products Group (a division of NCH Corporation) and as General Manager of the AT Plastics (EVA) division at Celanese Corporation. Prior to his general management roles, David was a management consultant for McKinsey & Company. He began his professional career as a chemical engineer at Exxon Corporation.

Thomas Stanley

Director

Thomas Stanley is a seasoned R&D professional with experience in plastics, silicones, and water treatment industries. Tom’s career has spanned over 32 years and includes positions at General Electric and Suez Water Technologies and Solutions. Tom holds advanced degrees in Chemical Engineering including a PhD from U of Pennsylvania.